Article
Antiviral Therapy Inhibited HBV-reactivation and Improved Long-term Outcomes in Patients Who Underwent Radiofrequency Ablation for HBV-related Hepatocellular Carcinoma
2022-10-26
Abstract excerpt
<h4>Background: </h4> The study aimed to examine the impact of antiviral therapy (AVT) on hepatitis B virus (HBV) reactivation and long-term outcomes after percutaneous radiofrequency ablation (PRFA) for HBV-related hepatocellular carcinoma (HCC). <h4>Methods: </h4>: Data on 538 consecutive patients who underwent PRFA for early-stage HBV-related HCC between 2009 and 2013 were reviewed. Propensity score matching (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f337e6a-5d9b-588f-964e-387f790eaf87
- DOI
- 10.21203/rs.3.rs-2145210/v1
